Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 25
Phase 32
Phase 42

Trial Status

Completed12
Terminated2

Role Distribution

Principal Investigator14
PI Rate100%

Activity Timeline

Clinical Trials (14)

NCT02899962Phase 3Completed
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
Psoriasis Vulgaris
PrincipalinvestigatorStart date: 2017-02-15
NCT01865032Completed
Evaluation of CL Detectâ„¢ Rapid Test to Detect Cutaneous Leishmaniasis
Skin Diseases
PrincipalinvestigatorStart date: 2013-06-01
NCT01525875Phase 2Completed
Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
Pseudoxanthoma Elasticum
Principalinvestigator
NCT02168244Not ApplicableCompleted
Reduction of Pain Caused by Biologic Drugs in Psoriasis
PainPsoriasis
Principalinvestigator

Showing 10 of 14 trials

Research Network

Collaboration Network

63 collaborators·109 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Bukhalo, MD

Altman Dermatology Associates

Related
4 trials

Shared therapeutic areas:

Keratosis, ActinicPsoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score24%

George J Murakawa, MD PhD

Somerset Skin Centre

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Walter Nahm, MD PhD

Walter Nahm, MD, Ph.D., Inc

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

James A Solomon, MD PhD

Ameriderm Research

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Chernila Selbert Alan, MD

DBA Torrance Clinical Research

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Jerry Bagel, MD

Psoriasis Treatment Center of Central NJ

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Joseph F Fowler, MD

Dermatology Specialists

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Alan Menter, MD

Division of Dermatology, Baylor Research Institute, USA

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Scott Glazer, MD

Glazer Dermatology

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Jeffrey Moore, MD

Deaconess Clinic, Inc.

Related
1 trials

Shared therapeutic areas:

Psoriasis Vulgaris

Worked with same sponsors:

LEO Pharma
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (14)

Showing 14 of 14 trials

NCT03403036Phase 4PrincipalInvestigator

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Psoriasis
Completed
NCT03123016Phase 2PrincipalInvestigator

Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo

Vitiligo
Completed
NCT02899962Phase 3PrincipalInvestigator

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Psoriasis Vulgaris
Completed
NCT01865032PrincipalInvestigator

Evaluation of CL Detectâ„¢ Rapid Test to Detect Cutaneous Leishmaniasis

Skin Diseases
Completed
NCT01188928Phase 3PrincipalInvestigator

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

Psoriasis Vulgaris
Completed
NCT01525875Phase 2PrincipalInvestigator

Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

Pseudoxanthoma Elasticum
Completed
NCT01836367Phase 1PrincipalInvestigator

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Actinic Keratosis
Completed
NCT01836939Phase 1PrincipalInvestigator

Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis
Completed
NCT01855880Phase 2PrincipalInvestigator

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Moderate to Severe Chronic Plaque Psoriasis
Completed
NCT02168244Not ApplicablePrincipalInvestigator

Reduction of Pain Caused by Biologic Drugs in Psoriasis

PainPsoriasis
Completed
NCT02181790Phase 4PrincipalInvestigator

Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and Soles

Psoriasis, Skin or Nails
Terminated
NCT02223039Phase 2PrincipalInvestigator

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Moderate to Severe Chronic Plaque Psoriasis
Completed
NCT02411851Phase 1PrincipalInvestigator

Treatment of Actinic Keratoses (AK) on the Face

Actinic Keratoses
Completed
NCT02599129Phase 2PrincipalInvestigator

A Study of Secukinumab for the Treatment of Alopecia Areata

Alopecia Areata
Terminated

All 14 trials loaded